Game Of Pharma start a new podcast series where we are trying to reduce the gap between the industry experts and the students. Here, we are also aware the people about the diseases by talking to experts.
97% of pharmaceutical companies rely on "me too" generic molecules to survive. How do you skip the generic trap and build a ₹200 Crore patent led powerhouse from scratch, starting just 10 days before a nationwide lockdown?In this episode of Game of Pharma, host Lokesh Sharma sits down with Rakesh Maitre, Senior Vice President at Celagenex and a 30 year pharmaceutical industry veteran (ex Ranbaxy, ex Piramal, ex Abbott), to unpack how scientific differentiation and a people first culture can disrupt the healthcare market.While most pharma startups struggle with field force attrition and crowded molecule spaces, Celagenex built three ₹30 Crore+ brands by focusing entirely on patented, endogenous molecules in gap area therapies like child neurology, stroke rehabilitation, and anti aging sirtuins. Rakesh sir reveals the exact blueprint behind recruiting 100 employees in 20 days without an existing sales pipeline, maintaining zero salary cuts during the pandemic, earning government recognition on Kartavya Path under Atmanirbhar Bharat Yojana, and developing an exclusive endogenous GLP 1 therapy designed for weight loss without muscle loss.Discover what it takes to transition from entry level field sales to top corporate leadership, how to manage customer psychology in medical detailing, and the core operational principles for scaling a high growth pharma company in India.Subscribe to Game of Pharma for more deep dive conversations with global healthcare and pharmaceutical leaders!If you found value in this episode, LIKE, SHARE, and COMMENT your key takeaway below!What We Cover in This EpisodeThe COVID 19 Lockdown Survival Playbook: Joining as Employee #1, hiring 100 people in 20 days, and executing hospital sanitization strategies to gain doctor access during peak lockdown.Escaping the "Me Too" Generic Trap: Why 97% of pharma companies fail to innovate and how Celagenex pivoted to a 100% patent driven, endogenous molecule strategy.Exclusive GLP 1 Industry Reveal: Celagenex's revolutionary endogenous GLP 1 therapy designed for weight loss without muscle degradation.Niche Therapeutic Breakthroughs: Commercializing first in class treatments for Autism/ADHD, neurodevelopmental delays (NDD), sirtuin based cardiology, and male/female infertility.The "R&D" Growth Blueprint: How US based R&D (80+ filed patents, 60+ clinical trials, DMF approved APIs) paired with a high trust culture built a ₹200 Cr enterprise.The People First Retention Engine: Why promoting 65% of field force members internally (from Medical Rep to National Sales Manager) creates long term organizational sustainability.National Recognition: The story behind being honored on Kartavya Path under Atmanirbhar Bharat Yojana and recognized publicly by Union Minister Piyush Goyal.Connect & Follow UsHost & Guest Profiles:Guest (Rakesh Maitre) - https://www.linkedin.com/in/rakesh-maitre-2101ab17/Host - https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Game of Pharma Socials:Website - https://gameofpharma.com/ LinkedIn - https://www.linkedin.com/company/game-of-pharma/posts/?feedView=all Instagram - https://www.instagram.com/gameofpharma/ Newsletter - https://game-of-pharma.beehiiv.com/ Listen to the Audio Podcast:Spotify - https://open.spotify.com/show/4EDgDoeQ8psKel9aZ8CC2F Apple Podcasts - https://podcasts.apple.com/us/podcast/game-of-pharma-podcast/id1825092913?l=pt-BR
Pharma companies are spending billions on AI and automation, yet most projects remain trapped in "pilot purgatory". Why is digital transformation so difficult to scale on the manufacturing floor?In this episode of Game of Pharma, host Lokesh Sharma sits down with Jonathon Thompson, Global Director of the Digital Center of Excellence at CAI. Drawing from a 25-year career arc,starting as a bench chemist on Eli Lilly's insulin line in 1999 to leading global automation strategies at Baxter, Avivia, and CAI—Jonathon reveals what it actually takes to move beyond AI hype into scalable operational value.Key Topics Covered:• From Bench Chemist to IT Leader: The LIMS & EBR Transition• Why Pharma Under-Invests in Manufacturing AI vs. R&D• Root Causes of "Pilot Purgatory" & How to Break Free• Boardroom Expectations vs. Plant-Floor Operational Reality• Big Pharma Tech Debt vs. Agile Biotech Startups• The Hidden AI Opportunity in Tech Transfer & Scale-Up• Micro-AI Solutions vs. Big-Bang Software Implementations• Build, Buy, or Partner? Navigating AI Vendor Selection• AI Founder vs. Pharma Founder Startup ModelsConnect with Guest & Host:Jonathon Thompson (CAI) / jonathon-thompson-1052906 Lokesh Sharma (Game of Pharma) / lokesh-sharma-7250a71a9
10,000 amputations happen every single day in India due to chronic wounds like diabetic foot ulcers, a silent epidemic hiding in plain sight. In this episode of Game of Pharma, host Lokesh Sharma sits down with Tarun Bansal, Co-founder of MedVital and former key leader at Pristyn Care and EY, to unpack how advanced medical devices can solve India's massive healthcare white spaces. While India has proven its dominance in global pharma, the medical device sector remains drastically underpenetrated. Tarun breaks down how MedVital is disrupting wound care through accessible Negative Pressure Wound Therapy (NPWT), chitosan-based liquid bandages made from seafood waste, and sheep tissue-derived extracellular matrices to drive complete skin restoration. Discover why medical devices are poised to follow pharma's high-growth trajectory, the realities of scaling a B2B MedTech startup, and how to change doctor adoption behavior on the ground.Subscribe to Game of Pharma for more deep-dive conversations with global healthcare and pharmaceutical leaders!Subscribe for Elite Business & Pharma Insights: / @gameofpharma-podcast Connect with Tarun Bansal on LinkedIn: / tarun-bansal-6a61b3a LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
Why are commercial insurance systems structurally built to reject permanent medical cures? In this episode of Game of Pharma, host Lokesh Sharma sits down with Dr. Elizabeth Aden, Ex-SVP of Global Pharma Strategy at Roche and Advisor at SPARK at Stanford to unpack the hidden economic machinery behind drug development, portfolio allocation, and commercial launch strategy.From the financial trap of chasing 3% of a mega-market to why US payers prefer funding annual chronic maintenance over one-time $80,000 cures, this conversation exposes the boardroom calculus that dictates global healthcare.WHAT WE COVER IN THIS EPISODE:• Commercial Profits vs. Community Cures: Why fragmented payer models penalize curative single-dose therapies.• The 80/3 Portfolio Equation: Why owning 80% of a targeted niche yields superior bottom-line returns over chasing a volatile 3% of a broad disease market.• The Drug Repurposing Opportunity: Why companies spend billions developing new molecules from scratch while golden assets gather dust in corporate archives.• Promotional Overhead & Marketing Friction: How sales and marketing expenses quietly devour blockbuster drug profitability.• Stanford SPARK Insights: Translating academic discoveries into commercially viable startups.CONNECT WITH DR. ELIZABETH ADENLinkedIn: / elizabeth-reed-aden EXPLORE THE FICTION SIDE OF PHARMA STRATEGY:Interested in how personalized medicine, genetic profiling, and prescription dosing collide in a high-stakes medical thriller? Check out Dr. Elizabeth Aden's bestseller The Goldilocks Genome.Get it on Amazon: https://www.amazon.in/Goldilocks-Geno...CONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma ABOUT OUR GUEST:Dr. Elizabeth Aden is a veteran pharmaceutical executive, board member, and author. She previously served as Senior Vice President & International Director of Global Pharma Strategy at Roche, where she managed global portfolio research across six international sites. She is currently an Advisor at SPARK at Stanford, a board member at JVS Medical, and has led multiple biotech companies dedicated to recovering shelved pharmaceutical assets.ABOUT GAME OF PHARMA:Game of Pharma is one of the bes podcast for life science professionals, corporate strategists, student researchers, and biotech entrepreneurs exploring the intersection of medicine, market access, and commercial strategy.
Is "work-life balance" in your 20s a lie? Should you job-hop every 2 years to grow, or is corporate loyalty still worth it?In this deep-dive episode of Game of Pharma, host Lokesh Sharma sits down with Anand Agarwal (Senior Vice President & Regional Head at Cipla). From his humble beginnings in a small town in Rajasthan (Abu Road) to completing 25 years at Cipla and leading international markets, Anand shares unfiltered career truths for young professionals, freshers, medical reps, and corporate leaders.Key Highlights in This Episode:The "Balanced Life" Framework: Why separating "work" from "life" is flawed, and why 100% presence beats work-life balance.Advice for Fresh Medical Reps (MRs): How to navigate the initial field grind, upskill, and avoid burnout.The 20s Money Trap: Why chasing overhyped wealth and comparing yourself to internet founders can ruin your personal life.25 Years at ONE Company: Why Anand stayed at Cipla for a quarter-century and what makes a company worth staying at.The 3 Non-Negotiable Pillars: Growth, Earnings, and Respect—the real metric for deciding whether to stay or switch jobs.What Gen Z Wants: Why respect in the workplace is the ultimate retention factor for the next generation.Subscribe to Game of Pharma for more deep-dive conversations with global healthcare and pharmaceutical leaders!Subscribe for Elite Business & Pharma Insights: / @gameofpharma-podcast Connect with Anand Agarwal on LinkedIn: / anandagarwal-leadership LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
What does it take to scale a career across the global pharmaceutical industry over 38 years? In this podcast, N. Chandrasekaran, Associate Vice President at NATCO Pharma (Ex-Sandoz, Ex-Novartis, Ex-Biocon), breaks down the unwritten rules of corporate pharma growth, commercial sales team execution, and executive leadership.If you are a Medical Representative (MR), Area Business Manager (ABM), or pharmaceutical professional looking to grow into executive positions, this episode provides a practical blueprint. Chandrasekaran shares a contrarian take on corporate culture, declaring organization culture a myth and explaining why leadership rests entirely with line managers. He details how to manage remote field teams over Zoom, leverage the 5W blueprint to convert raw effort into sales goals, and apply the golden rule of executive communication: praise in public, critique in private.Looking for a proven pharma sales strategy, a clear career growth plan, or actionable team management advice from top life sciences executives? This detailed discussion covers pharmaceutical commercial operations, MNC vs Indian pharma corporate frameworks, and field force execution metrics. Learn how to navigate the shift from entry-level medical representative roles to high-level regional manager positions, track field force effort logs without micro-managing, pitch high-priced innovator molecules, and use the 5W framework to align remote field teams over online meetings.Connect with N. Chandrasekaran on LinkedIn: / n-chandrasekaran-23b73572 LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
What does it take to scale a career across the global pharmaceutical industry over 38 years? In this podcast, N. Chandrasekaran, Associate Vice President at NATCO Pharma (Ex-Sandoz, Ex-Novartis, Ex-Biocon), breaks down the unwritten rules of corporate pharma growth, commercial sales team execution, and executive leadership.If you are a Medical Representative (MR), Area Business Manager (ABM), or pharmaceutical professional looking to grow into executive positions, this episode provides a practical blueprint. Chandrasekaran shares a contrarian take on corporate culture, declaring organization culture a myth and explaining why leadership rests entirely with line managers. He details how to manage remote field teams over Zoom, leverage the 5W blueprint to convert raw effort into sales goals, and apply the golden rule of executive communication: praise in public, critique in private.Looking for a proven pharma sales strategy, a clear career growth plan, or actionable team management advice from top life sciences executives? This detailed discussion covers pharmaceutical commercial operations, MNC vs Indian pharma corporate frameworks, and field force execution metrics. Learn how to navigate the shift from entry-level medical representative roles to high-level regional manager positions, track field force effort logs without micro-managing, pitch high-priced innovator molecules, and use the 5W framework to align remote field teams over online meetings.Connect with N. Chandrasekaran on LinkedIn: / n-chandrasekaran-23b73572 LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
How do you survive and dominate an Indian pharma market where 60,000 generic brands launch every single year? Dr. Vijay Charlu (President - India Business, Corona Remedies Limited) breaks down the ultimate playbook for molecule selection, market disruption, and successful brand acquisitions.The rules of the pharmaceutical industry have fundamentally shifted. Traditional marketing is dead, and market disruption is the new norm. In this episode of Game of Pharma, we sit down with Dr. Vijay Charlu to uncover why scaling matters more than product value, how to spot portfolio gaps, and the real reason most private equity pharma acquisitions fail (Hint: It's not the money).If you are a pharma executive, marketer, entrepreneur, or investor looking to understand the mechanics of the Indian drug market, this masterclass is for you.If you found this breakdown valuable, don't forget to Like, Subscribe, and hit the Notification Bell to stay ahead of the curve in the pharma ecosystem!Connect with Dr. Vijay Charlu on LinkedIn: / vijaycharlu LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comHost LinkedIn - / lokesh-sharma-7250a71a9 Follow us on social media - Website : https://gameofpharma.com/Instagram : https://www.instagram.com/gameofpharm...LinkedIn : / game-of-pharma-podcast
How do you survive and dominate an Indian pharma market where 60,000 generic brands launch every single year? Dr. Vijay Charlu (President - India Business, Corona Remedies Limited) breaks down the ultimate playbook for molecule selection, market disruption, and successful brand acquisitions.The rules of the pharmaceutical industry have fundamentally shifted. Traditional marketing is dead, and market disruption is the new norm. In this episode of Game of Pharma, we sit down with Dr. Vijay Charlu to uncover why scaling matters more than product value, how to spot portfolio gaps, and the real reason most private equity pharma acquisitions fail (Hint: It's not the money).If you are a pharma executive, marketer, entrepreneur, or investor looking to understand the mechanics of the Indian drug market, this masterclass is for you.If you found this breakdown valuable, don't forget to Like, Subscribe, and hit the Notification Bell to stay ahead of the curve in the pharma ecosystem!Connect with Dr. Vijay Charlu on LinkedIn: / vijaycharlu LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comHost LinkedIn - / lokesh-sharma-7250a71a9 Follow us on social media - Website : https://gameofpharma.com/Instagram : https://www.instagram.com/gameofpharm...LinkedIn : / game-of-pharma-podcast
How did a local Indian health platform secure millions from Japanese giant Mitsubishi, sell a majority stake to Flipkart, and then pull off a historic buyback when global strategies shifted?In this episode of Game of Pharma by Game Of Pharma, host Lokesh sits down with Mr. B.L. Mittal, the legendary founder of SastaSundar. Mr. Mittal cracks open the reality of the Indian healthcare ecosystem, pulling back the curtain on how a business built on "Tech + Empathy" disrupted the complex digital retail pharmacy space.From growing up in rural Rajasthan and unlocking the foundational philosophies of the "Marwari Business Code" to navigating multi-million dollar equity deals, Mr. Mittal's journey is a clinic in masterclass unit economics. He outlines the dangerous landscape where 50% of rural Indian prescriptions are dictated by unqualified practitioners, the tragic personal events that fueled his healthcare vision, and why traditional retail models consistently outperform over-leveraged tech startups. If you want to understand structural risk management, sustainable corporate scaling, and why PharmEasy's aggressive expansion patterns structuralized a deep decline, this conversation is an absolute necessity.Key Topics Explored:The calculated mechanics behind the historic 10-minute Flipkart-SastaSundar buyback deal.Brand Architecture: Why simple experience-driven taglines disrupt markets faster than premium naming agencies.The Hub and Spoke logistics model that maintains structural profitability without zero-margin inventory.Why Indian pharma spaces under-invest in core R&D compared to global operations like Eli Lilly.Pragmatic advice for early-stage entrepreneurs looking to preserve equity and drive cash-flow longevity.Subscribe to Game Of Pharma for weekly masterclasses with global healthcare pioneers.Formulate your strategies directly via our network profiles.Subscribe for Elite Business & Pharma Insights: / @gameofpharma-podcast Connect with on LinkedIn: / blmittal LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
Looking to accelerate your career in the pharmaceutical industry? Discover how to become a successful Medical Representative and fast-track your path to corporate leadership with field-tested sales and marketing strategies from a top industry veteran. In this exclusive masterclass, M. Megnathan, Senior Vice President at Apex Laboratories, breaks down the complete blueprint for pharma stakeholder management, clinic effectiveness, and out-of-the-box territory execution.Whether you are a B.Pharma student exploring career options, a management graduate looking into pharma marketing, or an active sales executive trying to hit targets in an over-saturated landscape, this masterclass reveals the structural realities of field execution. Learn the exact scientific communication scripts needed to win the respect of highly qualified doctors, the behavioral techniques required to turn local retail chemists into data partners, and the tactical protocols to leverage stockists for competitor intelligence.Key Discussion PointsThe psychological shift required to see the Medical Representative role as an elite leadership incubator.Why desk-bound corporate management tracks fail without real field sales training roots.The Technical Communication Script: Matching the intellectual and scientific baselines of highly qualified doctors.The Retail Chemistry Protocol: Extracting clean territory data during precise leisure-hour windows.The Stockist Alignment Framework: Harnessing wholesale distribution partners for real-time trade competitor intelligence.Out-of-the-Box Adaptation: Survival metrics under the pressure of 60,000+ yearly generic product launches. Connect with M. Megnathan on LinkedIn: / meganathan-mohan-97641b14 LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma
What happens when a 16-year Google veteran (who also worked at Microsoft) decides to fix drug discovery with AI?You get Pauling AI, a next-generation molecular simulation platform built to discover the medicines of tomorrow.In this episode of Game of Pharma, Javier, CEO & Founder of Pauling AI and Ex-Technical Director at Google Healthcare & Life Sciences, shares his journey from leading Search, Ads, Supply Chain, and Cloud at Google (with prior experience at Microsoft) to building AI tools that could shape the future of pharmaceutical research.What you'll learn in this episode:→ Why Javier left Google after 16 years to bet on biotech AI→ What's actually working in AI drug discovery (vs the hype)→ Why biotech startups adopt AI faster than Big Pharma→ How Pauling AI is reimagining molecular simulation→ The next 5 years of AI in pharmaIf you're curious about where AI meets drug discovery, this conversation is unmissable.️ Listen on Spotify: https://open.spotify.com/show/4EDgDoe...️ Apple Podcasts: https://podcasts.apple.com/us/podcast...Subscribe to our newsletter: https://game-of-pharma.beehiiv.com---ABOUT JAVIER:Javier is a technology executive, and entrepreneur. Currently leading Pauling AI, a next-generation molecular simulation platform.Previously: 16 years at Google (Search, Ads, Supply Chain, Cloud). Prior experience at Microsoft and McKinsey.Education: Superior Engineer in Computer Science, Masters in Mathematics (Dropped out of Ph.D. in Mathematics to pursue building software.)ABOUT GAME OF PHARMA:World's leading pharma podcast with 25,000+ subscribers globally. Featuring conversations with the brightest minds in pharmaceuticals.Website: https://gameofpharma.com/LinkedIn: / game-of-pharma-podcast
Why do US pharma companies struggle in India's generic drug market, and what does the future hold for US-India collaboration?Dr. Marschall Runge, Former CEO of the University of Michigan Medical School and former Board of Directors at Eli Lilly, breaks down the competitive dynamics between US innovation-driven pharma and India's generic drug dominance.In this conversation, we discuss:Why US companies can't compete on generics (and shouldn't try)India's untapped opportunity in biosimilarsThe Mark Cuban Cost Plus Drugs modelUS-India pharma partnerships: realistic or wishful thinking?How AI will transform healthcare deliveryWhy obesity is the #1 health problem to solveThe problem with Pharmacy Benefit Managers (PBMs)Healthcare as business vs. common goodDr. Runge's take: "India has excelled at high-quality drugs at low cost. US companies focused on patent drugs with higher margins. But I see tremendous opportunity for collaboration, especially in biosimilars.ABOUT DR. MARSCHALL RUNGE:Dr. Runge is Former CEO of the University of Michigan Medical School and a distinguished physician. He previously served on the Independent Directors at Eli Lilly and is a leading advocate for integrating advanced technology into healthcare systems.His expertise spans academic medicine, pharmaceutical innovation, and healthcare policy.CONNECT WITH DR. RUNGE:LinkedIn: / marschallsrunge LISTEN ON PODCAST:Apple Podcasts: https://podcasts.apple.com/us/podcast...Spotify: https://open.spotify.com/show/4EDgDoe...Website: https://gameofpharma.com/GAME OF PHARMA NEWSLETTER:Weekly pharma insights delivered to your inboxSubscribe: https://game-of-pharma.beehiiv.comCONNECT WITH HOST - LOKESH SHARMALinkedIn: / lokesh-sharma-7250a71a9 FOLLOW GAME OF PHARMA:LinkedIn: / game-of-pharma-podcast Instagram: / gameofpharma Website: https://gameofpharma.com
What really makes a pharma brand succeed?Is it the molecule?The marketing budget?Or the people on the ground?In this episode of Leaders of Pharma, we have Sumit Bhattacharjee, who started his journey as a Medical Representative in 1990 and went on to work across Nicholas Piramal, UCB, Dr. Reddy's, Zydus Cadila, and now Exeltis India.With 36 years of hands on experience, he shares what actually works in pharma marketing→ building trust with doctors, strengthening retailer relationships, empowering field teams, and adapting to the rise of generics and e-pharmacies.This conversation is practical, and rooted in real industry experience.If you are a Medical Representative, Pharma Marketer, or someone trying to understand how this industry truly works,then this episode is for you.Watch the episode and let us know:What do you think matters more in pharma - product, promotion, or people?Guest LinkedIn - / sumit-bhattacharjee-6b0a8315 Host LinkedIn - / lokesh-sharma-7250a71a9 Follow us on social media - Website : https://gameofpharma.com/Instagram : https://www.instagram.com/gameofpharm...LinkedIn : / game-of-pharma-podcast
What happens when a first-generation entrepreneur who's transformed 500+ brands sits down to expose pharma's biggest secret? Creative Mediocrity.In this explosive conversation, Aleem Merchant—TEDx speaker, 40under40 winner, and founder of Synapse (one of India's most respected award-winning agencies)—reveals why the pharmaceutical industry refuses to innovate and how playing it safe has become the most dangerous strategy.With over two decades of experience working with the world's best brands across FMCG, luxury, IT, and his specialty—Healthcare & Pharmaceuticals—Aleem shares the uncomfortable truths that pharma marketers know but won't say out loud.ABOUT ALEEM MERCHANT:Aleem is a brand consultant, thought-leader, creative marketeer, digital marketing pro, author, blogger, and podcaster—all rolled into one. As the Founder and Director of Synapse, he's built one of India's most respected advertising and marketing agencies.His philosophy: Creativity isn't just craft—it's the solution to business problems and market opportunities. He's consulted and created strategies for 500+ brands, earning international awards and the trust of leading companies across industries.His expertise in Healthcare and Pharmaceuticals makes this conversation especially powerful—he's seen firsthand what works, what doesn't, and why pharma keeps choosing mediocrity.PERFECT FOR:Pharma marketers & CMOsHealthcare marketing professionalsBrand strategists in regulated industriesAgency professionalsEntrepreneurs in healthcare/pharmaAnyone frustrated with industry conservatismIf this conversation challenged your thinking, hit LIKE and SUBSCRIBE for more industry-disrupting conversations.Connect with Aleem - / aleemmerchant Connect with Lokesh - / lokesh-sharma-7250a71a9 Follow us on social media - Website : https://gameofpharma.com/Instagram : https://www.instagram.com/gameofpharm...LinkedIn : / game-of-pharma-podcast
In this special bonus episode, we explore the transformative impact of Shark Tank India on grassroots innovation and entrepreneurship across the country. From inspiring small-scale businesses to fostering a culture of creativity and opportunity, discover how the show is shaping India's entrepreneurial spirit from the ground up.Tune in for insights, success stories, and discussions on the ripple effect of Shark Tank India.Deepesh's LinkedIn: / deepeshrajpal Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: / gameofpharma LinkedIn: / game-of-pharma
Discover how Pharmallama, as a pharma startup, navigated the intense world of Shark Tank and successfully secured 5 remarkable deals! In this podcast, he shares his journey of innovation, persistence, and strategic pitching that caught the attention of the Sharks.Get insider insights into:The challenges of pitching as a pharma startupHow we prepared for the Shark Tank spotlightLessons learned from the Sharks that transformed our businessWhether you're an entrepreneur, innovator, or just curious about the Shark Tank experience, this episode is packed with inspiration and actionable advice.Deepesh's LinkedIn: / deepeshrajpal Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: / gameofpharma LinkedIn: / game-of-pharma
In this episode, we dive deep into the world of pharma startups with Deepesh Rajpal, the founder of LifeCare Pharmacy, Pharmallama, and Onedose.ai. Join us as we explore the challenges, risks, and lessons learned while building successful ventures in the highly regulated pharma industry. From navigating regulatory hurdles to managing investor expectations, Deepesh shares his invaluable insights and candid experiences about what it truly takes to succeed as a pharma entrepreneur.Whether you're an aspiring founder, a professional in the pharma industry, or just curious about the startup journey, this podcast offers a real, unfiltered look into the highs and lows of building a pharma startup.Deepesh's LinkedIn: / deepeshrajpal Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: / gameofpharma LinkedIn: / game-of-pharma
In this episode of the Leaders of Pharma Podcast by Game of Pharma and Live Pharma Coalition, we sit down with Bharat Solanki, Founder & Managing Director of AI SANTE MEDITECH PVT LTD and BIOS LAB PVT LTD, to explore his remarkable journey from pharmaceutical entrepreneurship to AI-driven healthcare innovation.What You'll Learn:How Bharat built two successful companies in pharma and AI technologyThe "grow with people" philosophy that transformed his businessWhy AI SANTE MEDITECH is revolutionizing pharmaceutical operationsSecrets to managing multiple healthcare ventures simultaneouslyHow traditional pharma labs can embrace AI and digital transformationReal-world applications of artificial intelligence in pharmaceutical manufacturingLeadership strategies for scaling healthcare businessesKey Takeaways:Why the pharmaceutical industry needs AI integration NOWHow to build a people-centric culture in healthcare businessesLessons from managing multiple healthcare venturesThe future of AI in pharmaceuticalHost's Linkedin - https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Website - https://gameofpharma.com/Instagram - https://www.instagram.com/gameofpharma/Linkedin - https://www.linkedin.com/company/game-of-pharma/
In this episode of the Leaders of Pharma Podcast by Game of Pharma and Live Pharma Coalition, we feature Rahul Shankar, CEO of Arya Pharmalab Nepal, who shares his remarkable journey from his early days in the pharma industry to leading one of Nepal's most respected pharmaceutical companies.Discover how his leadership mindset, strategic decisions, and people-first approach shaped Arya Pharmalab's growth. This episode is packed with insights on pharma leadership, entrepreneurship, and the decision-making process of a CEO, valuable for every professional aiming to grow in the pharma business.Host's LinkedIn: / lokesh-sharma-7250a71a9 Follow us on social media-Website: https://gameofpharma.com/Instagram: / gameofpharma LinkedIn: / game-of-pharma
What does it really take to start a pharma company from scratch? In this episode, we feature Shivshankar Maurya, Founder and Director of Yuderma, who started his journey as a Medical Representative and went on to build a successful dermatology company. Hear his inspiring story of determination, strategy, and passion that turned a simple dream into a thriving pharma business.This episode is part of the exclusive Game of Pharma x Live Pharma Coalition Podcast Series, where we bring you real stories of pharma entrepreneurs and leaders who are shaping the future of the pharmaceutical industry in India. Tune in to learn what it takes to build a pharma startup, overcome industry challenges, and create an impact that inspires the next generation of healthcare professionals.Shivshankar Maurya's LinkedIn: / shivshankar-maurya-07500738 Host's LinkedIn: / lokesh-sharma-7250a71a9 YuDerma Website: https://yuderma.com/Follow us on social media-Website: https://gameofpharma.com/Instagram: / gameofpharma LinkedIn: / game-of-pharma
The obesity market is experiencing the most explosive growth in modern pharmaceutical history. With the rise of GLP-1 medications and a flood of semaglutide generics entering the market, the landscape is shifting from clinical discovery to a massive battle for market access and positioning.In this episode of Game of Pharma, Lokesh sits down with Dr. Evan Nadler to decode the reality of this multi-billion-dollar therapeutic gold rush. We move past the consumer hype and break down the commercial realities of metabolic treatments.In this episode, we cover:The GLP-1 Gold Rush: How the massive surge in obesity therapeutics is fundamentally changing pharmaceutical brand strategy.The Access Gap: Why the gap in treatment access is the single biggest opportunity (and hurdle) in healthcare right now.US vs. India: Comparing the structural differences between the US and Indian markets regarding metabolic therapies.Semaglutide Positioning: How pharma companies must position their branded generics to win the long game in a highly saturated market.Whether you are a pharma marketer, brand manager, or healthcare executive, this conversation provides a strategic roadmap for navigating the biggest market shift in a generation.#PharmaStrategy #GLP1 #ObesityMarket #PharmaMarketing #HealthcareInnovation #GameOfPharma #Semaglutide #BestPharmaPodcastDr. Nadler's LinkedIn: https://www.linkedin.com/in/evanpnadler/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
The obesity market is experiencing the most explosive growth in modern pharmaceutical history. With the rise of GLP-1 medications and a flood of semaglutide generics entering the market, the landscape is shifting from clinical discovery to a massive battle for market access and positioning.In this episode of Game of Pharma, Lokesh sits down with Dr. Evan Nadler to decode the reality of this multi-billion-dollar therapeutic gold rush. We move past the consumer hype and break down the commercial realities of metabolic treatments.In this episode, we cover:The GLP-1 Gold Rush: How the massive surge in obesity therapeutics is fundamentally changing pharmaceutical brand strategy.The Access Gap: Why the gap in treatment access is the single biggest opportunity (and hurdle) in healthcare right now.US vs. India: Comparing the structural differences between the US and Indian markets regarding metabolic therapies.Semaglutide Positioning: How pharma companies must position their branded generics to win the long game in a highly saturated market.Whether you are a pharma marketer, brand manager, or healthcare executive, this conversation provides a strategic roadmap for navigating the biggest market shift in a generation.#PharmaStrategy #GLP1 #ObesityMarket #PharmaMarketing #HealthcareInnovation #GameOfPharma #Semaglutide #BestPharmaPodcastDr. Nadler's LinkedIn: https://www.linkedin.com/in/evanpnadler/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Most people still think of China as just a generics producer. They are dead wrong. In just one decade, China has transformed from "copycat" to cutting-edge, and now Big Pharma is licensing assets from China, not just to it.In this episode of Game of Pharma, Lokesh sits down with Dr. Julien Willard, former senior intelligence officer, health economist, and strategy executive at Accenture and IBM, to decode what is really happening in global biotech.In this episode, we cover:The Big Shift: The single biggest sign China's pharma industry has fundamentally changed.The Gold Rush: Why global pharmaceutical companies are scrambling for Chinese biotech assets.Speed to Market: How clinical trials that take years in the West are being executed in months in Shanghai.The US vs. China: What Western pharma should (and absolutely shouldn't) copy from China's aggressive playbook.If you make decisions in pharma, biotech, healthcare strategy, or investment, this conversation will change how you see the next decade of the industry.#PharmaStrategy #BiotechTrends #ClinicalTrials #HealthcareInvestment #PharmaMarketing #DrugDevelopment #Pharma #Biotech #Pharmaceuticals #LifeSciences #HealthcareInnovationJulien's LinkedIn: https://www.linkedin.com/in/julienwillard/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Most people still think of China as just a generics producer. They are dead wrong. In just one decade, China has transformed from "copycat" to cutting-edge, and now Big Pharma is licensing assets from China, not just to it.In this episode of Game of Pharma, Lokesh sits down with Dr. Julien Willard, former senior intelligence officer, health economist, and strategy executive at Accenture and IBM, to decode what is really happening in global biotech.In this episode, we cover:The Big Shift: The single biggest sign China's pharma industry has fundamentally changed.The Gold Rush: Why global pharmaceutical companies are scrambling for Chinese biotech assets.Speed to Market: How clinical trials that take years in the West are being executed in months in Shanghai.The US vs. China: What Western pharma should (and absolutely shouldn't) copy from China's aggressive playbook.If you make decisions in pharma, biotech, healthcare strategy, or investment, this conversation will change how you see the next decade of the industry.#PharmaStrategy #BiotechTrends #ClinicalTrials #HealthcareInvestment #PharmaMarketing #DrugDevelopment #Pharma #Biotech #Pharmaceuticals #LifeSciences #HealthcareInnovationJulien's LinkedIn: https://www.linkedin.com/in/julienwillard/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
The future of clinical trials and pharmacovigilance relies heavily on patient data, but integrating that data is a massive challenge. With countless touchpoints and messy data formats across different devices, how can the pharmaceutical industry actually make sense of it all?In this episode of Game of Pharma, Lokesh sits down with Marco Benitez, the CEO and founder of ROOK. Marco brings a wealth of experience to the table, having previously served as the Head of Medical Affairs at Roche before founding his tech company. We dive deep into how ROOK is solving the healthcare industry's fragmented data problem.In this episode, we cover:The ROOK API Solution: How ROOK integrates data from over 300 wearables—including Apple Watch, Polar, Garmin, and Huawei—into a single API platform.Data Harmonization: The process of cleaning, standardizing, and harmonizing wearable data so that it is AI-ready for clinical trials and insurance companies.The Big Pivot: How the pandemic forced ROOK to pivot from a fitness club hardware model (tracking heart rates on screens) into a massive B2B data science company.Marco's Journey: Marco shares his incredible entrepreneurial path, starting from building a hospital algorithm at just 19 years old, to navigating Big Pharma, to pitching his multi-billion dollar data vision.If you are working in clinical trials, healthcare tech, or digital strategy, this episode provides a clear roadmap on how unstructured wearable data is being transformed into actionable insights.#WearableTech #ClinicalTrials #DigitalHealth #PharmaInnovation #HealthData #GameOfPharmaMarco's LinkedIn: https://www.linkedin.com/in/marcobzg/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
The future of clinical trials and pharmacovigilance relies heavily on patient data, but integrating that data is a massive challenge. With countless touchpoints and messy data formats across different devices, how can the pharmaceutical industry actually make sense of it all?In this episode of Game of Pharma, Lokesh sits down with Marco Benitez, the CEO and founder of ROOK. Marco brings a wealth of experience to the table, having previously served as the Head of Medical Affairs at Roche before founding his tech company. We dive deep into how ROOK is solving the healthcare industry's fragmented data problem.In this episode, we cover:The ROOK API Solution: How ROOK integrates data from over 300 wearables—including Apple Watch, Polar, Garmin, and Huawei—into a single API platform.Data Harmonization: The process of cleaning, standardizing, and harmonizing wearable data so that it is AI-ready for clinical trials and insurance companies.The Big Pivot: How the pandemic forced ROOK to pivot from a fitness club hardware model (tracking heart rates on screens) into a massive B2B data science company.Marco's Journey: Marco shares his incredible entrepreneurial path, starting from building a hospital algorithm at just 19 years old, to navigating Big Pharma, to pitching his multi-billion dollar data vision.If you are working in clinical trials, healthcare tech, or digital strategy, this episode provides a clear roadmap on how unstructured wearable data is being transformed into actionable insights.#WearableTech #ClinicalTrials #DigitalHealth #PharmaInnovation #HealthData #GameOfPharmaMarco's LinkedIn: https://www.linkedin.com/in/marcobzg/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
What does real omnichannel marketing look like in today's pharma world?In this episode of Game of Pharma, we sit down with Nick Smith—Founder of Loud Canvas Health and ex-Eversana leader, to unpack what's changed in pharma omnichannel, why personalization beats presence, and how behavior data can reshape brand strategy. Nick has worked on both niche and large-scale brands and shares powerful insights on:Aligning brand goals with HCP and payer behaviorCreating omnichannel journeys that actually convertWhy rep visits are still gold (if tracked right)Structuring websites for different stakeholdersUsing omnichannel maturity models to future-proof brand plansWhether you're in brand, marketing, or access strategy, this episode will challenge the way you think about omnichannel in pharma. Don't forget to like, and hit the follow icon to stay updated with new episodes!#OmnichannelMarketing #PharmaMarketing #HealthcareStrategy #GameOfPharma #NickSmith #DigitalHealth #PatientCentric #HCPengagement #PayerStrategy #MarketingPodcastNick's LinkedIn: https://www.linkedin.com/in/therealnicksmith/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
What does real omnichannel marketing look like in today's pharma world?In this episode of Game of Pharma, we sit down with Nick Smith—Founder of Loud Canvas Health and ex-Eversana leader, to unpack what's changed in pharma omnichannel, why personalization beats presence, and how behavior data can reshape brand strategy. Nick has worked on both niche and large-scale brands and shares powerful insights on:Aligning brand goals with HCP and payer behaviorCreating omnichannel journeys that actually convertWhy rep visits are still gold (if tracked right)Structuring websites for different stakeholdersUsing omnichannel maturity models to future-proof brand plansWhether you're in brand, marketing, or access strategy, this episode will challenge the way you think about omnichannel in pharma. Don't forget to like, and hit the follow icon to stay updated with new episodes!#OmnichannelMarketing #PharmaMarketing #HealthcareStrategy #GameOfPharma #NickSmith #DigitalHealth #PatientCentric #HCPengagement #PayerStrategy #MarketingPodcastNick's LinkedIn: https://www.linkedin.com/in/therealnicksmith/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
What if your medicines could be delivered faster than your pizza and by your trusted local pharmacist?In this episode of 21 Min Pharma Edge powered by Game of Pharma, we sit down with Kaushal Shah, the visionary behind eVitalRx and PillO, two startups that are redefining how India experiences pharmacy. From disrupting traditional retail chemists to building a digital backbone for pharmacies, Kaushal Shah walks us through his bold vision for the future. In this episode, we cover:The idea behind delivering medicines in under 60 minutesHow PillO partners with local pharmacies to challenge the giantsBalancing speed, safety, and trust in healthcare delivery If you're curious about the intersection of healthcare, tech, and Indian innovation — this one's a must-watch. Don't forget to like, comment, and subscribe for more episodes of Game of Pharma.Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. #PharmaTech #eVitalRx #PillO #HealthcareInnovation #GameOfPharma #PharmacyStartup #QuickCommerce #HealthDelivery #IndianStartups #KaushalShah #21minpharmaedge #pharmapodcast #pharmacy #pharmacist Kaushal Shah's LinkedIn: https://www.linkedin.com/in/kaushalshah06/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
What if your medicines could be delivered faster than your pizza and by your trusted local pharmacist?In this episode of 21 Min Pharma Edge powered by Game of Pharma, we sit down with Kaushal Shah, the visionary behind eVitalRx and PillO, two startups that are redefining how India experiences pharmacy. From disrupting traditional retail chemists to building a digital backbone for pharmacies, Kaushal Shah walks us through his bold vision for the future. In this episode, we cover:The idea behind delivering medicines in under 60 minutesHow PillO partners with local pharmacies to challenge the giantsBalancing speed, safety, and trust in healthcare delivery If you're curious about the intersection of healthcare, tech, and Indian innovation — this one's a must-watch. Don't forget to like, comment, and subscribe for more episodes of Game of Pharma.Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. #PharmaTech #eVitalRx #PillO #HealthcareInnovation #GameOfPharma #PharmacyStartup #QuickCommerce #HealthDelivery #IndianStartups #KaushalShah #21minpharmaedge #pharmapodcast #pharmacy #pharmacist Kaushal Shah's LinkedIn: https://www.linkedin.com/in/kaushalshah06/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– Key trends shaping the infusion therapy market – The biggest challenge health systems face today – Why infusion services are a critical part of modern care – Can India become the next big hub for infusion startups? – A rapid-fire round with fresh insights and fun!This is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation.Stay tuned with us!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #pharmapodcast #infusionindustry #pharmaindustryAvailable on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– Key trends shaping the infusion therapy market– The biggest challenge health systems face today– Why infusion services are a critical part of modern care– Can India become the next big hub for infusion startups?– A rapid-fire round with fresh insights and fun!This is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation.Stay tuned with us!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #pharmapodcast #infusionindustry #pharmaindustryAvailable on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– His real-life journey from B.Pharm to VP at McKesson– Why he chose pharmacy and what kept him going– The evolving trend of pharmacy grads moving abroad– Key differences in work culture: India vs the U.S.– Insights into the infusion and specialty pharmacy industry– His leadership learnings and advice for the next generationThis is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation. Stay tuned for Part 2—where we dive deeper into the infusion industry!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #globalpharmacareer #pharmawarriors #indianpharma #pharmapodcast Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode, we sit down with Dr. Prateek Bhatia, Vice President & GM at Intrafusion by McKesson, to uncover his inspiring journey from being a pharmacy student in Pune, India to leading one of the most crucial verticals in the U.S. healthcare system. What you'll learn:– His real-life journey from B.Pharm to VP at McKesson– Why he chose pharmacy and what kept him going– The evolving trend of pharmacy grads moving abroad– Key differences in work culture: India vs the U.S.– Insights into the infusion and specialty pharmacy industry– His leadership learnings and advice for the next generationThis is a must-watch for pharmacy students, young professionals, and anyone curious about global healthcare leadership and innovation. Stay tuned for Part 2—where we dive deeper into the infusion industry!Don't forget to like, comment, and subscribe for more insights on innovation and disruption in healthcare.#Gameofpharma #globalpharmacareer #pharmawarriors #indianpharma #pharmapodcast Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Prateek's LinkedIn: https://www.linkedin.com/in/prateek-bhatia/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Why is pharma still lagging in the quick commerce revolution?In this thought-provoking episode, we sit down with Sharad Harjai – Startup Growth Consultant and ex-leader at Delivery Hero, PharmEasy, and Blinkit – to explore why the healthcare sector hasn't yet cracked the 10-minute delivery model.We discuss:The rapid rise of quick commerce in IndiaWhy medicines are missing from the top Q-commerce categoriesChallenges unique to pharma logistics and regulationsHow the industry can adopt instant delivery modelsGlobal trends in Q-commerce that could reshape healthcare deliveryIf you're in healthcare, pharma, logistics, or just curious about the future of fast delivery, this one's for you!Don't forget to like, comment, and share for more insights on innovation and disruption in healthcare.#Gameofpharma #quickcommerce #instantdelivery #epharmacy #pharmapodcast Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Sharad's LinkedIn: https://www.linkedin.com/in/sharadharjai/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Why is pharma still lagging in the quick commerce revolution?In this thought-provoking episode, we sit down with Sharad Harjai – Startup Growth Consultant and ex-leader at Delivery Hero, PharmEasy, and Blinkit – to explore why the healthcare sector hasn't yet cracked the 10-minute delivery model.We discuss:The rapid rise of quick commerce in IndiaWhy medicines are missing from the top Q-commerce categoriesChallenges unique to pharma logistics and regulationsHow the industry can adopt instant delivery modelsGlobal trends in Q-commerce that could reshape healthcare deliveryIf you're in healthcare, pharma, logistics, or just curious about the future of fast delivery, this one's for you!Don't forget to like, comment, and share for more insights on innovation and disruption in healthcare.#Gameofpharma #quickcommerce #instantdelivery #epharmacy #pharmapodcast Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Sharad's LinkedIn: https://www.linkedin.com/in/sharadharjai/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode of 21 Min Pharma Edge, we sit down with Ashok Bhatia, Former President – Emerging Markets at Zydus Group, to explore why Africa is fast becoming a strategic focus for global pharmaceutical companies.From navigating healthcare access gaps to identifying ROI potential, this conversation dives deep into:Why pharma is thinking beyond home marketsThe rise of Africa in pharma expansion strategiesKey healthcare challenges and innovation opportunities in African nationsCultural pitfalls to avoid when entering new marketsA practical 24-month roadmap for pharma market entryRapid-fire fun on regulations, data, supply chains & more!This is a must-watch for pharma leaders, strategists, and innovators looking to make real impact in emerging markets. Don't forget to like, share, and subscribe for more conversations that decode the evolving world of pharma!#Gameofpharma #GlobalPharma #PharmaExpansion #IndianPharma #AfricaPharmaAvailable on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Ashok Sir's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
In this episode of 21 Min Pharma Edge, we sit down with Ashok Bhatia, Former President – Emerging Markets at Zydus Group, to explore why Africa is fast becoming a strategic focus for global pharmaceutical companies.From navigating healthcare access gaps to identifying ROI potential, this conversation dives deep into:Why pharma is thinking beyond home marketsThe rise of Africa in pharma expansion strategiesKey healthcare challenges and innovation opportunities in African nationsCultural pitfalls to avoid when entering new marketsA practical 24-month roadmap for pharma market entryRapid-fire fun on regulations, data, supply chains & more!This is a must-watch for pharma leaders, strategists, and innovators looking to make real impact in emerging markets. Don't forget to like, share, and subscribe for more conversations that decode the evolving world of pharma!#Gameofpharma #GlobalPharma #PharmaExpansion #IndianPharma #AfricaPharmaAvailable on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Ashok Sir's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Welcome to our latest podcast episode featuring Dr. Amrit Karmarkar, Sr. Manager – HR & L&D at Zuventus Healthcare!In this insightful conversation, we explore: ️ How pharma careers have evolved in the digital age️ What hiring managers actually look for in resumes️ The great salary debate: Pharma vs. IT️ Emerging hiring trends – beyond campus placements and into AI-powered recruitment Whether you're a pharma student, a young professional, or someone curious about the future of the pharma industry, this episode is packed with real-world insights and career-shaping advice. Don't forget to like, share, and subscribe for more conversations that decode the evolving world of pharma!#Gameofpharma #PharmaSalaries #PharmaSales #PharmaCV #21MinPharma Edge #healthcare #careerinpharmacy Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Amrit's LinkedIn: https://www.linkedin.com/in/dr-amrit-karmarkar/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
Welcome to our latest podcast episode featuring Dr. Amrit Karmarkar, Sr. Manager – HR & L&D at Zuventus Healthcare!In this insightful conversation, we explore: ️ How pharma careers have evolved in the digital age️ What hiring managers actually look for in resumes️ The great salary debate: Pharma vs. IT️ Emerging hiring trends – beyond campus placements and into AI-powered recruitment Whether you're a pharma student, a young professional, or someone curious about the future of the pharma industry, this episode is packed with real-world insights and career-shaping advice. Don't forget to like, share, and subscribe for more conversations that decode the evolving world of pharma!#Gameofpharma #PharmaSalaries #PharmaSales #PharmaCV #21MinPharma Edge #healthcare #careerinpharmacy Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. Dr. Amrit's LinkedIn: https://www.linkedin.com/in/dr-amrit-karmarkar/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Follow us on social media-Website: https://gameofpharma.com/Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/
AI is transforming healthcare faster than ever—reducing physician burnout, cutting costs, and improving patient care. But how far can AI go? Can it truly fix the inefficiencies in our healthcare system?In this episode, we sit down with Kapil Shukla, Principal Architect at Google & Learner at Med-X AI, to explore how AI-driven automation, decision-making, and insurance navigation are shaping the future of medicine. From reducing appointment delays to making healthcare more affordable, we uncover the real impact of AI on doctors, patients, and the entire industry. Topics Covered: How AI is reducing administrative burdens for doctors AI's role in solving insurance complexities Improving patient experiences with AI-driven solutions Challenges in AI adoption—regulations, interoperability & trust The future of AI in healthcareListen now and follow for more expert discussions on healthcare innovation, AI, and digital transformation!Kapil's LinkedIn: https://www.linkedin.com/in/kshukla/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.comFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
AI is transforming healthcare faster than ever—reducing physician burnout, cutting costs, and improving patient care. But how far can AI go? Can it truly fix the inefficiencies in our healthcare system?In this episode, we sit down with Kapil Shukla, Principal Architect at Google & Learner at Med-X AI, to explore how AI-driven automation, decision-making, and insurance navigation are shaping the future of medicine. From reducing appointment delays to making healthcare more affordable, we uncover the real impact of AI on doctors, patients, and the entire industry. Topics Covered: How AI is reducing administrative burdens for doctors AI's role in solving insurance complexities Improving patient experiences with AI-driven solutions Challenges in AI adoption—regulations, interoperability & trust The future of AI in healthcareListen now and follow for more expert discussions on healthcare innovation, AI, and digital transformation!Kapil's LinkedIn: https://www.linkedin.com/in/kshukla/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.comFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
AI is transforming healthcare faster than ever—reducing physician burnout, cutting costs, and improving patient care. But how far can AI go? Can it truly fix the inefficiencies in our healthcare system?In this episode, we sit down with Kapil Shukla, Principal Architect at Google & Learner at Med-X AI, to explore how AI-driven automation, decision-making, and insurance navigation are shaping the future of medicine. From reducing appointment delays to making healthcare more affordable, we uncover the real impact of AI on doctors, patients, and the entire industry. Topics Covered: How AI is reducing administrative burdens for doctors AI's role in solving insurance complexities Improving patient experiences with AI-driven solutions Challenges in AI adoption—regulations, interoperability & trust The future of AI in healthcareListen now and follow for more expert discussions on healthcare innovation, AI, and digital transformation!Kapil's LinkedIn: https://www.linkedin.com/in/kshukla/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.comFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
AI is transforming healthcare faster than ever—reducing physician burnout, cutting costs, and improving patient care. But how far can AI go? Can it truly fix the inefficiencies in our healthcare system?In this episode, we sit down with Kapil Shukla, Principal Architect at Google & Learner at Med-X AI, to explore how AI-driven automation, decision-making, and insurance navigation are shaping the future of medicine. From reducing appointment delays to making healthcare more affordable, we uncover the real impact of AI on doctors, patients, and the entire industry. Topics Covered: How AI is reducing administrative burdens for doctors AI's role in solving insurance complexities Improving patient experiences with AI-driven solutions Challenges in AI adoption—regulations, interoperability & trust The future of AI in healthcareListen now and follow for more expert discussions on healthcare innovation, AI, and digital transformation!Kapil's LinkedIn: https://www.linkedin.com/in/kshukla/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
Medical congresses and Continuing Medical Education (CME) events have long been a cornerstone for pharma companies to connect with healthcare professionals (HCPs). But with rapid advancements in technology and changing engagement trends, how can these events stay relevant and impactful in 2025?In this episode, Arielle Smith, President of Life Sciences at Event Cadence, joins us to discuss:Why medical congresses and CME events remain essential for pharmaHow technology, AI, and data analytics are transforming HCP engagementThe role of hybrid and digital solutions in shaping the future of pharma eventsKey strategies to make your medical congress or CME more effective in 2025If you're in the life sciences industry, pharma marketing, or event planning, this episode is packed with insights you won't want to miss!Listen now and follow for more expert discussions on pharma innovation, AI, and digital transformation!Arielle's LinkedIn: https://www.linkedin.com/in/arielle-smith-965771a1/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw#MedicalCongress #CME2025 #PharmaEvents #HealthcareInnovation #HCPEngagement #PharmaMarketing #EventTech #DigitalHealth
Medical congresses and Continuing Medical Education (CME) events have long been a cornerstone for pharma companies to connect with healthcare professionals (HCPs). But with rapid advancements in technology and changing engagement trends, how can these events stay relevant and impactful in 2025?In this episode, Arielle Smith, President of Life Sciences at Event Cadence, joins us to discuss: Why medical congresses and CME events remain essential for pharma How technology, AI, and data analytics are transforming HCP engagement The role of hybrid and digital solutions in shaping the future of pharma events Key strategies to make your medical congress or CME more effective in 2025If you're in the life sciences industry, pharma marketing, or event planning, this episode is packed with insights you won't want to miss! Listen now and follow for more expert discussions on pharma innovation, AI, and digital transformation!Arielle's LinkedIn: https://www.linkedin.com/in/arielle-smith-965771a1/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw#MedicalCongress #CME2025 #PharmaEvents #HealthcareInnovation #HCPEngagement #PharmaMarketing #EventTech #DigitalHealth
In this episode of the 21 Min Pharma Edge powered by Game of Pharma, we sit down with Ashok Bhatia, former President - Emerging Markets at Zydus Lifesciences, to explore his remarkable 48-year journey in the pharma industry.In this podcast, we explore:The key ingredient for building a standout brand in today's competitive pharma world.How pharma companies approached brand management in the past and the valuable lessons we can still apply today, with a look at Nucoxia as an example.The biggest mistakes pharma companies are making in branding right now, with real-life examples that highlight what went wrong.Whether innovation and digital tools are making pharma branding easier or more complex, and what the future holds for this evolving landscape.Mr. Ashok's journey is a testament to hard work, innovation, and staying true to the basics while pushing boundaries.Whether you're a pharma professional, marketer, or someone passionate about leadership, this episode is packed with inspiration and actionable lessons.Don't miss this inspiring conversation!Follow to the Game of Pharma podcast for more exclusive interviews with pharma industry leaders.Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts.Mr. Ashok Bhatia's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
In this episode of the 21 Min Pharma Edge powered by Game of Pharma, we sit down with Ashok Bhatia, former President - Emerging Markets at Zydus Lifesciences, to explore his remarkable 48-year journey in the pharma industry.In this podcast, we explore:The key ingredient for building a standout brand in today's competitive pharma world.How pharma companies approached brand management in the past and the valuable lessons we can still apply today, with a look at Nucoxia as an example.The biggest mistakes pharma companies are making in branding right now, with real-life examples that highlight what went wrong.Whether innovation and digital tools are making pharma branding easier or more complex, and what the future holds for this evolving landscape.Mr. Ashok's journey is a testament to hard work, innovation, and staying true to the basics while pushing boundaries.Whether you're a pharma professional, marketer, or someone passionate about leadership, this episode is packed with inspiration and actionable lessons.Don't miss this inspiring conversation!Follow to the Game of Pharma podcast for more exclusive interviews with pharma industry leaders.Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts.Mr. Ashok Bhatia's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
In this episode of the 21 Min Pharma Edge powered by Game of Pharma, we sit down with Ashok Bhatia, former President - Emerging Markets at Zydus Lifesciences, to explore his remarkable 48-year journey in the pharma industry.From starting as an Assistant Chemist to becoming a leader in global markets, Mr. Ashok shares invaluable insights into:The evolution of pharma marketing over the decades.Overcoming challenges without digital tools in the early days.The art of brand building and creating sustainable profits.Defining moments that shaped his legacy in the industry.Mr. Ashok's journey is a testament to hard work, innovation, and staying true to the basics while pushing boundaries.Whether you're a pharma professional, marketer, or someone passionate about leadership, this episode is packed with inspiration and actionable lessons.Don't miss this inspiring conversation!Follow to the Game of Pharma podcast for more exclusive interviews with pharma industry leaders.Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts.Mr. Ashok Bhatia's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
In this episode of the 21 Min Pharma Edge powered by Game of Pharma, we sit down with Ashok Bhatia, former President - Emerging Markets at Zydus Lifesciences, to explore his remarkable 48-year journey in the pharma industry.From starting as an Assistant Chemist to becoming a leader in global markets, Mr. Ashok shares invaluable insights into: The evolution of pharma marketing over the decades. Overcoming challenges without digital tools in the early days. The art of brand building and creating sustainable profits. Defining moments that shaped his legacy in the industry.Mr. Ashok's journey is a testament to hard work, innovation, and staying true to the basics while pushing boundaries.Whether you're a pharma professional, marketer, or someone passionate about leadership, this episode is packed with inspiration and actionable lessons. Don't miss this inspiring conversation! Follow to the Game of Pharma podcast for more exclusive interviews with pharma industry leaders.Available on Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts.Mr. Ashok Bhatia's LinkedIn: https://www.linkedin.com/in/ashok-bhatia-6079a239/Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/Visit our website for the latest updates in pharma and to stay informed about future episodes: https://gameofpharma.inFollow us on social media-Instagram: https://www.instagram.com/gameofpharma/LinkedIn: https://www.linkedin.com/company/game-of-pharma/YouTube: https://www.youtube.com/channel/UCGLNWWSCYZz3WbY77gencpw
© 2020-2026 Ivy Podcast Discovery LLC
